The FGFR1 inhibitor PD173074 induces mesenchymal–epithelial transition through the transcription factor AP-1

Abstract

Taken together, these data suggest that PD173074 inhibits the MAPK pathway, which regulates the activity of AP-1 and induces MET. Furthermore, this induction of MET likely suppresses cancer cell growth and invasion.